DESONEX desloratadine 5 mg tablet film coated blister pack

Country: Awstralja

Lingwa: Ingliż

Sors: Department of Health (Therapeutic Goods Administration)

Ingredjent attiv:

desloratadine, Quantity: 5 mg

Disponibbli minn:

Bayer Australia Ltd

Għamla farmaċewtika:

Tablet, film coated

Kompożizzjoni:

Excipient Ingredients: maize starch; purified water; Carnauba Wax; microcrystalline cellulose; calcium hydrogen phosphate dihydrate; purified talc; titanium dioxide; lactose monohydrate; hypromellose; indigo carmine; macrogol 400

Rotta amministrattiva:

Oral

Unitajiet fil-pakkett:

2,3,5,7,10,14,15,20,25,28,30,42,45,50,60, 4, 1 tablet (sample pack), 40

Tip ta 'preskrizzjoni:

(S2) Pharmacy Medicine

Indikazzjonijiet terapewtiċi:

The rapid relief of symptoms associated with seasonal allergic rhinitis. The nasal symptoms of allergic rhinitis include rhinorrhoea, sneezing and nasal,itching. Allergic rhinitis is also associated with non-nasal symptoms such as ocular itching, tearing and itching of the eyes or palate., The relief of,symptoms associated with perennial allergic rhinitis. The symptomatic relief of itching and reduction in the size and number of hives associated with,chronic idiopathic urticaria.

Sommarju tal-prodott:

Visual Identification: Light blue round, central circular debossed on one side of the tablet, plain on the other side, film-coated tablets; Container Type: Blister Pack; Container Material: PVC/PCTFE (Aclar)/Al; Container Life Time: 2 Years; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

L-istatus ta 'awtorizzazzjoni:

Registered

Data ta 'l-awtorizzazzjoni:

2021-01-05